# Correction to: The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer

PMC · DOI: 10.1093/oncolo/oyad330 · The Oncologist · 2023-12-13

## Full-text entities

- **Diseases:** Breast Cancer (MESH:D001943), triple-negative breast cancer (MESH:D064726)
- **Chemicals:** atezolizumab (MESH:C000594389), Pembrolizumab (MESH:C582435)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** KEYNOTE-522 — Homo sapiens (Human), Xeroderma pigmentosum, complementation group C, Finite cell line (CVCL_M231)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10836320/full.md

---
Source: https://tomesphere.com/paper/PMC10836320